These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21358410)

  • 41. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
    Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
    J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duty to warn at-risk relatives for genetic disease: genetic counselors' clinical experience.
    Dugan RB; Wiesner GL; Juengst ET; O'Riordan M; Matthews AL; Robin NH
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):27-34. PubMed ID: 12704635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
    Ormondroyd E; Moynihan C; Watson M; Foster C; Davolls S; Ardern-Jones A; Eeles R
    J Genet Couns; 2007 Aug; 16(4):527-38. PubMed ID: 17492498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring relatives' perceptions of participation, ethics, and communication in a patient-driven study for hereditary cancer variant reclassification.
    Tsai GJ; Chen AT; Garrett LT; Burke W; Bowen DJ; Shirts BH
    J Genet Couns; 2020 Oct; 29(5):857-866. PubMed ID: 31916645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.
    Bednar EM; Rauh-Hain JA; Garcia JJ; de Aguinaga N; Powell MA; Peral SL; Nitecki R; Jorgensen K; Rudy NL; Lu KH; Leath CA; Scarinci IC
    Cancer Prev Res (Phila); 2024 Jan; 17(1):19-28. PubMed ID: 37913800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma.
    Peters MLB; Stobie L; Dudley B; Karloski E; Allen K; Speare V; Dolinsky JS; Tian Y; DeLeonardis K; Krejdovsky J; Button A; Lim C; Borazanci E; Brand R; Tung N
    Cancer; 2019 Jul; 125(14):2488-2496. PubMed ID: 30980401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
    BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors that influence cancer patients' and relatives' anxiety following a three-person medical consultation: impact of a communication skills training program for physicians.
    Lienard A; Merckaert I; Libert Y; Delvaux N; Marchal S; Boniver J; Etienne AM; Klastersky J; Reynaert C; Scalliet P; Slachmuylder JL; Razavi D
    Psychooncology; 2008 May; 17(5):488-96. PubMed ID: 17879970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of a chatbot to increase uptake of cascade genetic testing.
    Schmidlen T; Jones CL; Campbell-Salome G; McCormick CZ; Vanenkevort E; Sturm AC
    J Genet Couns; 2022 Oct; 31(5):1219-1230. PubMed ID: 35616645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics.
    Derbez B; de Pauw A; Stoppa-Lyonnet D; de Montgolfier S
    Fam Cancer; 2017 Jul; 16(3):447-457. PubMed ID: 28293859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Notification of a family history of breast cancer: issues of privacy and confidentiality.
    Winter PR; Wiesner GL; Finnegan J; Bartels D; LeRoy B; Chen PL; Sellers TA
    Am J Med Genet; 1996 Dec; 66(1):1-6. PubMed ID: 8957501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cascade testing after exome sequencing: Retrospective analysis of linked family data at 2 US laboratories.
    Stefka J; Streff H; Liu P; Towne M; Smith HS
    Genet Med; 2023 May; 25(5):100818. PubMed ID: 36852743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients' intentions to inform relatives about Type 2 diabetes risk: the role of worry in the process of family risk disclosure.
    van Esch SC; Nijkamp MD; Cornel MC; Snoek FJ
    Diabet Med; 2012 Dec; 29(12):e461-7. PubMed ID: 23003196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.
    van Dijk S; Otten W; Timmermans DR; van Asperen CJ; Meijers-Heijboer H; Tibben A; Breuning MH; Kievit J
    Genet Med; 2005 Apr; 7(4):239-45. PubMed ID: 15834241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Motivation and family communication in hereditary prostate cancer genetic testing: Survey of patients from a US tertiary medical center.
    Finn CM; McCormick S; Peterson D; Niendorf KB; Rodgers LH
    J Genet Couns; 2023 Feb; 32(1):79-89. PubMed ID: 35941805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.
    Elrick A; Ashida S; Ivanovich J; Lyons S; Biesecker BB; Goodman MS; Kaphingst KA
    J Genet Couns; 2017 Feb; 26(1):173-181. PubMed ID: 27422778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.
    Pedrazzani C; Aceti M; Schweighoffer R; Kaiser-Grolimund A; Bürki N; Chappuis PO; Graffeo R; Monnerat C; Pagani O; Rabaglio M; Katapodi MC; Caiata-Zufferey M
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 36013197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
    Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
    Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.